M. Hancock

发表

Race, sex, and the regulation of urine osmolality: observations made during water deprivation.

G. Eckert, L. Bankir, D. Bichet, 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia.

D. Campana, C. Pui, R. Ribeiro, 2002, Blood.

Current Treatment and Results of St. Jude Studies for Childhood Acute Lymphoblastic Leukemia

M. Relling, W. Evans, R. Ribeiro, 1994 .

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.

F. Behm, S. Raimondi, M. Relling, 2002, Pharmacogenetics.

Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries

C. Pui, R. Ribeiro, S. Howard, 2003, The Lancet.

Relationships Among Severity of Osteonecrosis, Pain, Range of Motion, and Functional Mobility in Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia

C. Pui, S. Rai, S. Kaste, 2008, Physical Therapy.

Selective androgen receptor modulators for the treatment of late onset male hypogonadism

J. Dalton, M. Steiner, C. Coss, 2014, Asian journal of andrology.

Selective androgen receptor modulators for the treatment of late onset male hypogonadism

J. Dalton, M. Steiner, C. Coss, 2014, Asian journal of andrology.

Effect of GTx-024, a selective androgen receptor modulator (SARM), on physical function in patients with non-small cell lung cancer (NSCLC) with cancer cachexia.

A. Dobs, M. Steiner, M. Hancock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of less than 8% weight loss on overall survival in subjects with non-small cell lung cancer (NSCLC) treated in a phase IIb trial of GTx-024.

A. Dobs, M. Steiner, M. Hancock, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishing the use of body mass index as an indicator of nutrition risk in children with cancer.

M. Hancock, G. Hale, K. Ringwald-Smith, 2004, JPEN. Journal of parenteral and enteral nutrition.

Characterization of a dexamethasone-treated rat model of cryptosporidial infection.

J. Rehg, M. Hancock, D. Woodmansee, 1988, The Journal of infectious diseases.

Characterization of cyclophosphamide-rat model of cryptosporidiosis

J. Rehg, M. Hancock, D. Woodmansee, 1987, Infection and immunity.

Clinical Presentation and Treatment Outcome of Children With Burkitt Lymphoma in Lebanon: A Single Institution's Experience

M. Hancock, M. Abboud, S. Muwakkit, 2004, Journal of pediatric hematology/oncology.

Factors associated with vertebral fractures in men treated with androgen-deprivation therapy (ADT) for prostate cancer.

M. Steiner, M. Hancock, P. Saylor, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia.

W. Evans, M. Hancock, G. Rivera, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer.

M. Steiner, A. Morgans, M. Hancock, 2012, The Journal of urology.

Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer.

W. Aronson, E. Yu, T. Flaig, 2020, Clinical genitourinary cancer.

Abstract P1-13-04: Enobosarm for the treatment of metastatic, estrogen and androgen receptor positive, breast cancer. Final results of the primary endpoint and current progression free survival

E. Winer, L. Parker, B. Overmoyer, 2015 .

Characterization ofCyclophosphamide-Rat Model ofCryptosporidiosi s

M. Hancock, D. Woodmansee, 1987 .

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

M. Relling, C. Pui, W. Evans, 2000, The Lancet.

TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

M. Rubin, D. Bostwick, C. Barbieri, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Leukemia Central Nervous System Relapse in Children With Acute Lymphoblastic Early Intensification of Intrathecal Chemotherapy Virtually Eliminates

M. Relling, R. Ribeiro, D. Head, 2013 .

Risk-Adapted Treatment for Acute Lymphoblastic Leukemia: Findings from St. Jude Children’s Research Hospital

M. Relling, W. Evans, R. Ribeiro, 1997 .

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

C. Pui, R. Peto, J. Peto, 1996, The Lancet.

Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia

M. Relling, C. Pui, M. Hudson, 2005, Cancer.

Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.

C. Pui, W. Evans, M. Hudson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

12p Abnormalities and the TEL Gene (ETV6) in Childhood Acute Lymphoblastic Leukemia

J. Downing, F. Behm, S. Raimondi, 1997 .

Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.

R. Mulhern, M. Hancock, G. Rivera, 1995, International journal of radiation oncology, biology, physics.

Progress in the treatment of adolescents with acute lymphoblastic leukemia

C. Pui, R. Ribeiro, W. Furman, 1993, Cancer.

Clinical Significance of CD 34 Expression in Childhood Acute Lymphoblastic Leukemia

F. Behm, C. Pui, A. Look, 2022 .

Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukemia

C. Pui, J. Rubnitz, M. Hancock, 2005, Pediatric blood & cancer.

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

Elaine Coustan-Smith, Dario Campana, Ching-Hon Pui, 1998, The Lancet.

Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression

B. Ring, S. Wrighton, S. Strom, 2003, Journal of Pharmacology and Experimental Therapeutics.

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

S. Taneja, M. Steiner, M. Hancock, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis

C. Pui, R. Khan, E. Lowe, 2005, Pediatric blood & cancer.

Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer.

J. Dalton, M. Steiner, E. Yu, 2015, European urology.

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

J. Dalton, M. Steiner, M. Hancock, 2011, Journal of cachexia, sarcopenia and muscle.

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

F. Behm, D. Campana, C. Pui, 2002, Blood.

The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.

J. Hudson, M. Boguski, M. Relling, 2001, Pharmacogenetics.

Transplantation in children Energy expenditure in children undergoing hematopoietic stem cell transplantation

R. Krance, H. Heslop, M. Hancock, 2002 .

High incidence of secondary brain tumours after radiotherapy and antimetabolites

M. Relling, C. Pui, W. Evans, 1999, The Lancet.

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors

R. McLendon, C. Fuller, M. Danks, 2006, Cancer.

Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up‐front treatment of acute lymphoblastic leukemia

M. Relling, C. Pui, W. Evans, 2003, Clinical pharmacology and therapeutics.

102 GTx-758, an ERα agonist, reduces serum free testosterone lower than can be achieved by leuprolide with a significantly lower rate of hot flashes in men with advanced prostate cancer

J. Dalton, M. Steiner, C. Coss, 2013 .

Effect of GTx-758, an ERα agonist, on serum-free testosterone and serum PSA in men with advanced prostate cancer.

J. Dalton, M. Steiner, C. Coss, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.

I. Pollack, H. Friedman, A. Murgo, 2007, Neuro-oncology.

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

M. Steiner, M. Hancock, S. Malkowicz, 2010, The Journal of urology.

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

J. Crawford, R. Gralla, J. Dalton, 2016, Current Oncology Reports.

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

A. Dobs, J. Dalton, M. Steiner, 2013, The Lancet. Oncology.

PharmGKB Update: II. CYP3A5, Cytochrome P450, Family 3, Subfamily A, Polypeptide 5

E. Cook, M. Boguski, F. Behm, 2004, Pharmacological Reviews.

Pleurodesis for effusions in pediatric oncology patients at end of life

P. Hinds, S. Rai, M. Hancock, 2007, Pediatric Radiology.

Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.

M. Steiner, M. Hancock, P. Saylor, 2011, The Journal of urology.

De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo.

M. Relling, C. Pui, W. Evans, 2002, Blood.

Enobosarm: A targeted therapy for metastatic, androgen receptor positive, breast cancer.

B. Overmoyer, J. Dalton, M. Steiner, 2014 .

Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer.

M. Brawer, M. Steiner, M. Hancock, 2011, The Journal of urology.

The effect of low-dose GTx-758 on free testerone levels in men with metastatic castration resistant prostate cancer (mCRPC).

J. Dalton, M. Steiner, E. Yu, 2014 .

Second malignancy after treatment of childhood non‐Hodgkin lymphoma

C. Pui, W. Evans, R. Ribeiro, 2001, Cancer.

disease in children with acute lymphoblastic leukemia Use of peripheral blood instead of bone marrow to monitor residual

C. Pui, R. Ribeiro, E. Coustan-Smith, 2002 .

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

F. Behm, S. Raimondi, W. Evans, 1991, The Lancet.

Phase I Trial of Intrathecal Spartaject Busulfan in Children with Neoplastic Meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004)

H. Friedman, W. Petros, P. Phillips, 2006, Clinical Cancer Research.

Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.

F. Behm, M. Relling, C. Pui, 1998, Blood.

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

M. Relling, C. Pui, W. Evans, 1999, Journal of the National Cancer Institute.

Hormone levels following surgical and medical castration: defining optimal androgen suppression

M. Schweizer, E. Yu, R. Getzenberg, 2017, Asian journal of andrology.

Treatment of acute lymphoblastic leukemia : 30 years' experience at St. Jude Children's Research Hospital

M. Hancock, G. Rivera, D. Pinkel, 1993 .

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

F. Behm, S. Raimondi, M. Relling, 2000, Leukemia.

Acute Lymphoid Leukemia Outcomes in Black and White Children-Reply

Ken R. Smith, C. Pui, M. Hancock, 1995 .

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

F. Behm, S. Raimondi, C. Pui, 1991, The New England journal of medicine.

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

F. Behm, S. Raimondi, D. Campana, 2000, Blood.

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1999, Blood.

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia.

C. Pui, A. Gajjar, M. Hancock, 1995, Blood.

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

F. Behm, C. Pui, R. Krance, 1993, The New England journal of medicine.

Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.

F. Behm, S. Raimondi, C. Pui, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine

M. Relling, C. Pui, W. Evans, 2002, Leukemia.

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.

J. Downing, S. Shurtleff, F. Behm, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic tools like ANDROTEST have estimated a disease incidence of 10%–40% in men aged over 45 years and suggest that up to 60 million men in the United States, Europe and Japan suffer

J. Dalton, M. Steiner, C. Coss, 2020 .

Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup

J. Downing, F. Behm, M. Relling, 1999, Leukemia.

Parenteral nutrition associated with increased infection rate in children with cancer

J. Gattuso, M. Hancock, B. Pharm., 1993, Cancer.

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

S. Shurtleff, F. Behm, S. Raimondi, 1995, Leukemia.

Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia.

F. Behm, S. Raimondi, C. Pui, 1996, Leukemia.

Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.

S. Raimondi, M. Relling, C. Pui, 1995, Leukemia.

Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.

J. Downing, F. Behm, S. Raimondi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in the acute lymphoid and myeloid leukemias of infants.

F. Behm, S. Raimondi, D. Campana, 1996, Leukemia.

METHOTREXATE, IN VIVO OF MERCAPTOPURINE ALONE OR IN COMBINATION WITH DE NOVO PURINE SYNTHESIS INHIBITION AND ANTILEUKEMIC EFFECTS

M. Relling, W. Evans, R. Ribeiro, 2013 .

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

D. Campana, C. Pui, R. Ribeiro, 2004, Leukemia.

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts

S. Raimondi, C. Pui, W. Evans, 1997, Leukemia.

L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.

F. Behm, S. Raimondi, M. Relling, 1995, Leukemia.

An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.

C. Pui, R. Mulhern, R. Ribeiro, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital.

M. Hancock, G. Rivera, D. Pinkel, 1993, The New England journal of medicine.

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

S. Taneja, M. Steiner, M. Hancock, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Race, sex, and the regulation of urine osmolality: observations made during water deprivation.

G. Eckert, L. Bankir, D. Bichet, 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1997, The New England journal of medicine.